Article
European LeukemiaNet Clinical Signs and Symptoms as Prognostic Markers in Polycythemia Vera During Ruxolitinib
2026-07-02
Abstract excerpt
<title>Abstract</title> <p>European LeukemiaNet defines the clinical signs and symptoms (CSSs) of polycythemia vera (PV) as progressive splenomegaly, leukocytosis, thrombocytosis, inadequate hematocrit control, and cardiovascular risk factors. In PV patients receiving hydroxyurea, CSSs indicate a phenotype with higher thrombosis risk across the standard risk categories. However, the prognostic value of CSSs for t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 018e8f59-c30d-5c54-ba31-ccd056f7d52f
- DOI
- 10.21203/rs.3.rs-10081825/v1